Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound

Gene Therapy

Volumn 11, Issue 20, 2004, Pages 1532-1539

  Shimamura, M ^a   Sato, N ^a   Taniyama, Y ^a   Yamamoto, S ^a   Endoh, M ^a   Kurinami, H ^b   Aoki, M ^b   Ogihara, T ^b   Kaneda, Y ^a   Morishita, R ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Central nervous system; Microbubble; Naked DNA; Ultrasound

Indexed keywords

FS 069; LUCIFERASE; NAKED DNA; PLASMID DNA;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA TRANSFER; ECHOGRAPHY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GLIA CELL; MALE; MENINX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; TISSUE INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; DNA; GENE THERAPY; LUCIFERASES; MALE; MICROBUBBLES; MICROSCOPY, FLUORESCENCE; RATS; RATS, WISTAR; SAFETY; TRANSFECTION; ULTRASONICS;

EID: 5444243992     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302323     Document Type: Article

References (31)

1. Eck SL et al. Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN- beta): a phase I trial. Hum Gene Ther 2001; 12: 97-113.
2. Trask TW et al. Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther 2000; 1: 195-203.
3. During MJ, Kaplitt MG, Stern MB, Eidelberg D. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 2001; 12: 1589-1591.
4. Janson C et al. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum Gene Ther 2002; 13: 1391-1412.
5. Schnell MA et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 2001; 3: 708-722.
6. Dewey RA et al. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials. Nat Med 1999; 5: 1256-1263.
7. Hsich G, Sena-Esteves M, Breakefield XO. Critical issues in gene therapy for neurologic disease. Hum Gene Ther 2002; 13: 579-604.
8. Baumgartner I et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 2000; 132: 880-884.
9. Rosengart TK et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999; 100: 468-474.
10. Schwartz B et al. Gene transfer by naked DNA into adult mouse brain. Gene Therapy 1996; 3: 405-411.
11. Sekiguchi K, Yasuzumi F, Morishita R. Exogenous expression of hepatocyte growth factor (HGF) in rat striatum by naked plasmid DNA. Neurosci Res 2003; 45: 173-180.
12. Taniyama Y et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233-1239.
13. Endoh M et al. Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther 2002; 5: 501-508.
14. Mychaskiw II G et al. Optison (FS069) disrupts the blood-brain barrier in rats. Anesth Analg 2000; 91: 798-803.
15. Hynynen K et al. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). Ultrasound Med Biol 2003; 29: 473-481.
16. Cavaglia M et al. Regional variation in brain capillary density and vascular response to ischemia. Brain Res 2001; 910: 81-93.
17. Somia N, Verma IM. Gene therapy: trials and tribulations. Nat Rev Genet 2000; 1: 91-99.
18. Unger EC, Hersh E, Vannan M, McCreery T. Gene delivery using ultrasound contrast agents. Echocardiography 2001; 18: 355-361.
19. Taniyama Y et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Therapy 2002; 9: 372-380.
20. Tachibana K et al. Induction of cell-membrane porosity by ultrasound. Lancet 1999; 353: 1409.
21. Daffertshofer M, Fatar M. Therapeutic ultrasound in ischemic stroke treatment: experimental evidence. Eur J Ultrasound 2002; 16: 121-130.
22. Yukawa H et al. Adenoviral gene transfer of basic fibroblast growth factor promotes angiogenesis in rat brain. Gene Therapy 2000; 7: 942-949.
23. Shimamura M et al. HVJ-envelope vector for gene transfer into central nervous system. Biochem Biophys Res Commun 2003; 2: 464-471.
24. Albrecht PJ et al. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp Neurol 2002; 173: 46-62.
25. Gill SS et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003; 9: 589-595.
26. Kordower JH. In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease. Ann Neurol 2003; 53: S120-S132; discussion S132-S134.
27. Wang L et al. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Therapy 2002; 9: 381-389.
28. Georgievska B et al. Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector. Neuroreport 2002; 13: 75-82.
29. Behrens S et al. Transcranial ultrasound-improved thrombolysis: diagnostic versus therapeutic ultrasound. Ultrasound Med Biol 2001; 27: 1683-1689.
30. Nagai T et al. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 2002; 20: 87-90.
31. Tsujie M et al. Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 2001; 12: 949-954.